JP2006505622A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505622A5
JP2006505622A5 JP2005501280A JP2005501280A JP2006505622A5 JP 2006505622 A5 JP2006505622 A5 JP 2006505622A5 JP 2005501280 A JP2005501280 A JP 2005501280A JP 2005501280 A JP2005501280 A JP 2005501280A JP 2006505622 A5 JP2006505622 A5 JP 2006505622A5
Authority
JP
Japan
Prior art keywords
mic
examples
strains
mentioned
strains described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005501280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505622A (ja
JP4602903B2 (ja
Filing date
Publication date
Priority claimed from DE2002147233 external-priority patent/DE10247233A1/de
Priority claimed from DE10256405A external-priority patent/DE10256405A1/de
Application filed filed Critical
Priority claimed from PCT/EP2003/011203 external-priority patent/WO2004035569A2/de
Publication of JP2006505622A publication Critical patent/JP2006505622A/ja
Publication of JP2006505622A5 publication Critical patent/JP2006505622A5/ja
Application granted granted Critical
Publication of JP4602903B2 publication Critical patent/JP4602903B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005501280A 2002-10-10 2003-10-09 抗菌活性を有する新規化合物 Expired - Fee Related JP4602903B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2002147233 DE10247233A1 (de) 2002-10-10 2002-10-10 Neue Verbindungen, die Topoisomerase IV inhibieren
DE10256405A DE10256405A1 (de) 2002-12-02 2002-12-02 Neue Verbindungen, die Topoisomerase IV inhibieren
PCT/EP2003/011203 WO2004035569A2 (de) 2002-10-10 2003-10-09 Neue verbindungen mit antibakterieller aktivität

Publications (3)

Publication Number Publication Date
JP2006505622A JP2006505622A (ja) 2006-02-16
JP2006505622A5 true JP2006505622A5 (enExample) 2010-09-16
JP4602903B2 JP4602903B2 (ja) 2010-12-22

Family

ID=32108775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005501280A Expired - Fee Related JP4602903B2 (ja) 2002-10-10 2003-10-09 抗菌活性を有する新規化合物

Country Status (12)

Country Link
US (1) US7223776B2 (enExample)
EP (2) EP1551829B1 (enExample)
JP (1) JP4602903B2 (enExample)
KR (1) KR20050072432A (enExample)
CN (1) CN101817815A (enExample)
AT (1) ATE463494T1 (enExample)
AU (1) AU2003301414B8 (enExample)
BR (1) BR0315221A (enExample)
CA (1) CA2500320A1 (enExample)
DE (1) DE50312598D1 (enExample)
PL (1) PL375525A1 (enExample)
WO (1) WO2004035569A2 (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
JP4445753B2 (ja) 2002-01-29 2010-04-07 グラクソ グループ リミテッド アミノピペリジン誘導体
US7109213B2 (en) 2002-01-29 2006-09-19 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
ES2350977T3 (es) 2002-11-05 2011-01-28 Glaxo Group Limited Agentes antibacterianos.
AU2003303956A1 (en) 2002-11-05 2004-11-23 Smithkline Beecham Corporation Antibacterial agents
DE60324179D1 (de) 2002-12-04 2008-11-27 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
EP1796466A4 (en) 2004-06-15 2009-09-02 Glaxo Group Ltd ANTIBACTERIAL AGENTS
US20070254872A1 (en) * 2004-07-08 2007-11-01 Glaxo Group Limited Antibacterial Agents
EP1784410A4 (en) * 2004-08-09 2009-07-15 Glaxo Group Ltd ANTIBACTERIAL AGENTS
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JP4887297B2 (ja) * 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
CA2581057A1 (en) * 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
AU2006230364B2 (en) * 2005-03-31 2012-09-13 Janssen Pharmaceutica N.V. Bicyclic pyrazole compounds as antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
JO2952B1 (en) * 2005-08-03 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JP2009524643A (ja) * 2006-01-26 2009-07-02 アクテリオン ファーマシューティカルズ リミテッド テトラヒドロピラン抗生物質
DE602007010427D1 (de) * 2006-02-15 2010-12-23 Actelion Pharmaceuticals Ltd Antibiotische ethanol- oder 1,2-ethandiol-cyclohexyl-derivate
CA2643962A1 (en) * 2006-03-10 2007-09-20 Actelion Pharmaceuticals Ltd Antibiotic compounds
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
CL2007003693A1 (es) * 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
US9167869B2 (en) * 2007-04-07 2015-10-27 Dynasty Footwear, Ltd. Shoe with multi-component embedded strap
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
PT2137196E (pt) * 2007-04-20 2010-12-16 Glaxo Group Ltd Compostos tricíclicos contendo azoto como agentes antibacterianos
US8759348B2 (en) * 2007-05-17 2014-06-24 Helperby Therapeutics Limited Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
CA2689102C (en) * 2007-06-15 2016-07-26 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
WO2009128019A1 (en) 2008-04-15 2009-10-22 Actelion Pharmaceuticals Ltd Tricyclic antibiotics
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010045987A1 (en) * 2008-10-23 2010-04-29 Glaxo Group Limited Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
US8716280B2 (en) 2009-01-21 2014-05-06 Basilea Pharmaceutica Ag Bicyclic antibiotics
PT3192500T (pt) 2009-05-19 2021-01-05 Neuroderm Ltd Composições para a administração contínua de inibidores da dopa decarboxilase
DK2640358T3 (en) * 2010-11-15 2018-04-16 Neuroderm Ltd CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA-DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS THEREOF
EP2854764B1 (en) 2012-06-05 2018-12-12 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
CA2887375C (en) * 2012-10-10 2022-07-05 Vitas Pharma Research Pvt Ltd Inhibitors of dna gyrase for the treatment of bacterial infections
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
PL3777833T3 (pl) 2014-03-13 2024-03-25 Neuroderm Ltd. Kompozycje inhibitorów dekarboksylazy dopa
AR101674A1 (es) 2014-08-22 2017-01-04 Glaxosmithkline Ip Dev Ltd Uso de un compuesto tricíclico que contiene nitrógeno
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
US20230097866A1 (en) 2020-01-24 2023-03-30 Ohio State Innovation Foundation Bacterial topoisomerase inhibitors derived from isomannide
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US381462A (en) * 1888-04-17 Signments
NL265777A (enExample) * 1960-06-09
US5721237A (en) 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
AU2717899A (en) * 1998-01-26 1999-08-09 Smithkline Beecham Plc Quinoline derivatives as antibacterials
GB9914486D0 (en) * 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) * 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
FR2798656B1 (fr) * 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
CN1452619A (zh) * 2000-07-26 2003-10-29 史密斯克莱·比奇曼公司 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
EP1719770A3 (en) * 2000-09-21 2008-03-05 Smithkline Beecham Plc Quinoline derivatives as antibacterials
US6939871B2 (en) 2000-10-26 2005-09-06 Smithkline Beecham P.L.C. Benzoxazinone derivatives, their preparation and use
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments

Similar Documents

Publication Publication Date Title
BRPI0714170A2 (pt) Processos para a fabricação de 1,2-dicloroetano, de cloreto de vinila, e de cloreto de polivinila.
USD547254S1 (en) Wheel
USD578565S1 (en) Typeface
USD561976S1 (en) Glove
USD589082S1 (en) Franking system
USD568073S1 (en) Bench bracket
ATE355060T1 (de) 2-methoxymethyl-3-(3,4-dichlorophenyl)-8- azabicyclo (3.2.1)octantartrat-salze
USD555989S1 (en) Archaeological equipment sifter
Kagaya A Jita vocabulary
USD564442S1 (en) Tire
USD599078S1 (en) Glove
USD568026S1 (en) Glove
AU2003219334A1 (en) An assembly for use a handle, peg or the like
Kagaya A Gwere vocabulary
AU2005100232A4 (en) The game- top dog 21 or bust
AU2003905024A0 (en) The Ultimate Trainer - Body Glove
AU2005900833A0 (en) P.K.'s Quarterball
JP2005082569A5 (enExample)
AU2006900541A0 (en) The universal tradie's toolbox
AU2004902573A0 (en) The 'POWERWEEDER'
AU2003905022A0 (en) The Ultimate Trainer - Ball
AU2003902515A0 (en) The scoop
AU2003289618A1 (en) A compound, the preparation and the use thereof
AU2004907349A0 (en) Handling device No. 5
AU2005900374A0 (en) The fish hooka, new submission